[HTML][HTML] Hypoxia, partial EMT and collective migration: Emerging culprits in metastasis

K Saxena, MK Jolly, K Balamurugan - Translational oncology, 2020 - Elsevier
Epithelial-mesenchymal transition (EMT) is a cellular biological process involved in
migration of primary cancer cells to secondary sites facilitating metastasis. Besides, EMT …

[HTML][HTML] Epigenetic and breast cancer therapy: promising diagnostic and therapeutic applications

G Sher, NA Salman, AQ Khan, KS Prabhu… - Seminars in cancer …, 2022 - Elsevier
The global burden of breast cancer (BC) is increasing significantly. This trend is caused by
several factors such as late diagnosis, limited treatment options for certain BC subtypes …

Zinc-dependent regulation of ZEB1 and YAP1 coactivation promotes epithelial-mesenchymal transition plasticity and metastasis in pancreatic cancer

M Liu, Y Zhang, J Yang, H Zhan, Z Zhou, Y Jiang, X Shi… - Gastroenterology, 2021 - Elsevier
Background Pancreatic cancer is characterized by extensive metastasis. Epithelial-
mesenchymal transition (EMT) plasticity plays a critical role in tumor progression and …

Comparative study of transcriptomics-based scoring metrics for the epithelial-hybrid-mesenchymal spectrum

P Chakraborty, JT George, S Tripathi… - … in bioengineering and …, 2020 - frontiersin.org
The Epithelial–mesenchymal transition (EMT) is a cellular process implicated in embryonic
development, wound healing, and pathological conditions such as cancer metastasis and …

Epigenetic regulation of hybrid epithelial-mesenchymal cell states in cancer

RA Sample, MF Nogueira, RD Mitra, SV Puram - Oncogene, 2023 - nature.com
Epithelial-to-mesenchymal transition (EMT) is a process by which cells lose their epithelial
characteristics and gain mesenchymal phenotypes. In cancer, EMT is thought to drive tumor …

Targeting chromatin-remodeling factors in cancer cells: promising molecules in cancer therapy

FL Zhang, DQ Li - International Journal of Molecular Sciences, 2022 - mdpi.com
ATP-dependent chromatin-remodeling complexes can reorganize and remodel chromatin
and thereby act as important regulator in various cellular processes. Based on considerable …

Emerging roles of endoplasmic reticulum stress in the cellular plasticity of cancer cells

H Wang, K Mi - Frontiers in Oncology, 2023 - frontiersin.org
Cellular plasticity is a well-known dynamic feature of tumor cells that endows tumors with
heterogeneity and therapeutic resistance and alters their invasion–metastasis progression …

MBD3 promotes hepatocellular carcinoma progression and metastasis through negative regulation of tumour suppressor TFPI2

W Yan, Q Han, L Gong, X Zhan, W Li, Z Guo… - British Journal of …, 2022 - nature.com
Background The mechanism of recurrence and metastasis of hepatocellular carcinoma
(HCC) is complex and challenging. Methyl-CpG binding domain protein 3 (MBD3) is a key …

[HTML][HTML] Epigenetic feedback and stochastic partitioning during cell division can drive resistance to EMT

W Jia, S Tripathi, P Chakraborty, A Chedere… - Oncotarget, 2020 - ncbi.nlm.nih.gov
Epithelial-mesenchymal transition (EMT) and its reverse process mesenchymal-epithelial
transition (MET) are central to metastatic aggressiveness and therapy resistance in solid …

[HTML][HTML] Factors determining epithelial-mesenchymal transition in cancer progression

P Tomecka, D Kunachowicz, J Górczyńska… - International Journal of …, 2024 - mdpi.com
Epithelial-mesenchymal transition (EMT) is a process in which an epithelial cell undergoes
multiple modifications, acquiring both morphological and functional characteristics of a …